Medicines are chemicals or compounds used to cure, halt, or prevent disease; ease symptoms; or help in the diagnosis of illnesses. Though these medicine appears to be safe and well tolerated there is significant risk associated with them. The risks need to be balanced against their benefits and only medicines with a positive benefit-risk balance are authorized for marketing.
The pharmacovigilance system is designed to enable patients to benefit from medicines while making them as safe as possible by characterizing and minimizing/preventing the risk.
Pharmacovigilance process has made great progress in moving from reactive activity of collecting and reporting of suspected adverse drug reactions to a more proactive monitoring activity based on careful planning before the product is placed on the market.
Current pharmacovigilance systems are being reshaped by numerous global health trends:
With greater access to technology and information In our current health care environment, where we have greater access to technology and information than ever before, there’s an endless amount of data at our fingertips. This data spans a medicine’s lifecycle and can lead to a better understanding of the benefits and risks for patients.
In our current healthcare environment we have greater access to technology, information and an endless amount of data. This data spans a medicine’s lifecycle and can lead to a better understanding of benefits and risks for patients.
Advanced analytics, rule based systems, orchestration systems, automation and cognitive technologies are providing opportunities to transform pharmacovigilance from the process of collecting data and preparing information for regulators to creating a learning system to improve a drug’s risk-benefit profile, help providers select the optimal treatment, and increase product quality and patient safety.
Advanced technologies in Pharmacovigilance system:
Leave a Reply